1. Medtech Insight
  2. >>Geography

New Anti-Corruption Focus In Mexico May Include Medtech Scrutiny

 
• By Elizabeth Orr

Recently inaugurated Mexican President Andrés Manuel López Obrador campaigned on a promise to tackle the country’s corruption issues. Medtech Insight spoke to attorney Nicholas Berg, of Ropes & Gray, about what this may mean for device manufacturers doing business in Mexico.

New Mexican President Andres Manuel Lopez Obrador during an Indigenous ceremony as part of ceremony of the takeover as the new President of Mexico on December 01, 2018 in Mexico City - Image
New Mexican President Andres Manuel Lopez Obrador during an Indigenous ceremony as part of his inauguration on Dec. 1, 2018, in Mexico City. • Source: Shutterstock

New Mexican president Andrés Manuel López Obrador was swept into office last year on an anticorruption platform. Some observers expect his efforts to include reforms and increased regulation touching the medical device sector.

López Obrador, who was sworn into office Dec. 1, is a member of the National Regeneration Movement (MORENA) party. The party now holds a majority of seats in the National Congress and won most of the gubernatorial races in Mexico’s July 2018 elections

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Latin America

More from Geography

Tariffs Threaten Medtech Innovation And US Position As World Leader, Whitaker Tells Lawmakers

 
• By Brian Bossetta

During his testimony before US senators on the impact of tariffs on critical supply chains, AdvaMed’s Scott Whitaker said the Trump tariffs could jeopardize America’s preeminence in medtech. Other industry experts echoed similar concerns.

Califf Warns Progress May Be In Danger Due To ‘Decimated’ FDA Staff

 
• By Barnaby Pickering

In Vivo spoke to the previous commissioner of the US FDA about recent ongoings at the agency, and where he believes policy should be directed for patient and industry benefit.

What’s A Diagnostic? WHO Wants To Know

 
• By Elizabeth Orr

The World Health Organization is seeking input from stakeholders to create an official definition of the term ‘diagnostics.’ This initiative follows a 2023 resolution aimed at enhancing global diagnostics capacity; the definition, it is hoped, will help drive the creation of effective health policies. Comments will be accepted until 23 May.